Hawaii Medical Journal is an independently operated medical research publication reporting on clinical trials, peer-reviewed studies, and evidence-based findings from Hawaii and worldwide. Serving physicians, researchers, and healthcare professionals with rigorous, data-driven coverage of medical research across all specialties. https://hawaiimedicaljournal.org en-us Thu, 09 Apr 2026 19:23:42 GMT Copyright 2026 Hawaii Medical Journal submissions@hawaiimedicaljournal.org (Hawaii Medical Journal) submissions@hawaiimedicaljournal.org (Hawaii Medical Journal) 60 https://hawaiimedicaljournal.org/category/clinical-research/2026/04/senate-democrats-unveil-health-care-affordability-framework/ https://hawaiimedicaljournal.org/category/clinical-research/2026/04/senate-democrats-unveil-health-care-affordability-framework/ Thu, 09 Apr 2026 17:36:16 GMT Twelve Senate Democrats and the Center for American Progress release a health care cost control framework aimed at shaping future legislative priorities. Hawaii Medical Journal Staff Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-backs-domestic-drug-production-to-counter-china/ https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-backs-domestic-drug-production-to-counter-china/ Wed, 08 Apr 2026 18:01:11 GMT The FDA has proposed policies to boost domestic drug manufacturing, including giving U.S. generic makers a patent challenge head start over foreign rivals. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-delay-forces-kezar-life-sciences-to-close-its-doors/ https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-delay-forces-kezar-life-sciences-to-close-its-doors/ Tue, 07 Apr 2026 18:01:07 GMT A four-month FDA meeting cancellation proved fatal for Kezar Life Sciences, highlighting how regulatory delays can devastate small biotech companies. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-delays-force-kezar-life-sciences-to-shut-down/ https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-delays-force-kezar-life-sciences-to-shut-down/ Mon, 06 Apr 2026 18:01:16 GMT Kezar Life Sciences is winding down after FDA meeting cancellations disrupted its autoimmune hepatitis drug program, driving investors to withdraw funding. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/public-health/2026/04/trumps-100-drug-tariffs-what-you-need-to-know/ https://hawaiimedicaljournal.org/category/public-health/2026/04/trumps-100-drug-tariffs-what-you-need-to-know/ Sun, 05 Apr 2026 18:00:53 GMT Trump's 100% tariffs on imported brand-name drugs include tiered exemptions for companies committing to U.S. manufacturing and price reductions. Michael O'Connor Public Health https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-approves-lillys-orforglipron-trump-pharma-tariffs-loom/ https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-approves-lillys-orforglipron-trump-pharma-tariffs-loom/ Sat, 04 Apr 2026 18:01:09 GMT FDA approves Eli Lilly's oral obesity pill orforglipron (Foundayo) while Trump eyes 100% tariffs on imported pharmaceuticals and drug ingredients. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-eyes-reversal-on-peptide-compounding-ban/ https://hawaiimedicaljournal.org/category/clinical-research/2026/04/fda-eyes-reversal-on-peptide-compounding-ban/ Fri, 03 Apr 2026 18:01:15 GMT The FDA signals a reversal of its 2023 peptide compounding ban, raising patient safety concerns, while gene therapy researchers face manufacturing hurdles. James Liu Clinical Research https://hawaiimedicaljournal.org/category/public-health/2026/04/pharma-delays-european-drug-launches-over-us-pricing-policy/ https://hawaiimedicaljournal.org/category/public-health/2026/04/pharma-delays-european-drug-launches-over-us-pricing-policy/ Thu, 02 Apr 2026 18:01:18 GMT Drug manufacturers are delaying European launches as most-favored-nation pricing threatens to compress US revenues, reshaping global launch strategies in 2026. Keala Nakamura Public Health https://hawaiimedicaljournal.org/category/public-health/2026/04/trump-pushes-drug-pricing-legislation-in-2026/ https://hawaiimedicaljournal.org/category/public-health/2026/04/trump-pushes-drug-pricing-legislation-in-2026/ Wed, 01 Apr 2026 18:00:58 GMT The White House is circulating draft drug pricing legislation to major pharma companies, escalating Trump's push to reshape U.S. medication pricing policy. Hawaii Medical Journal Public Health https://hawaiimedicaljournal.org/category/cardiology/2026/03/bmj-retracts-prevent-taha8-stem-cell-heart-failure-trial/ https://hawaiimedicaljournal.org/category/cardiology/2026/03/bmj-retracts-prevent-taha8-stem-cell-heart-failure-trial/ Tue, 31 Mar 2026 18:00:55 GMT The BMJ has retracted the PREVENT-TAHA8 phase 3 trial on mesenchymal stem cells for heart failure due to data integrity and enrollment concerns. James Liu Cardiology https://hawaiimedicaljournal.org/category/oncology/2026/03/merck-acquires-terns-pharmaceuticals-for-67b-in-2026/ https://hawaiimedicaljournal.org/category/oncology/2026/03/merck-acquires-terns-pharmaceuticals-for-67b-in-2026/ Mon, 30 Mar 2026 04:04:48 GMT Merck's $6.7B acquisition of Terns Pharmaceuticals targets TERN-701, a leukemia drug that could shore up its oncology pipeline amid patent pressures. James Liu Oncology https://hawaiimedicaljournal.org/category/clinical-research/2026/03/sarepta-therapeutics-shares-surge-on-rare-disease-drug-data/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/sarepta-therapeutics-shares-surge-on-rare-disease-drug-data/ Mon, 30 Mar 2026 04:02:28 GMT Sarepta Therapeutics shares rose 20% after releasing early clinical data for two rare muscle-wasting disease candidates, SRP-1001 and SRP-1003. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/public-health/2026/03/parenting-challenges-in-primary-care-the-gp-workforce-gap/ https://hawaiimedicaljournal.org/category/public-health/2026/03/parenting-challenges-in-primary-care-the-gp-workforce-gap/ Mon, 30 Mar 2026 04:00:59 GMT The suspension of GP Helen Eisenhauser highlights how primary care systems fail to support physician-parents, especially women managing childcare demands. Michael O'Connor Public Health https://hawaiimedicaljournal.org/category/public-health/2026/03/ftc-settles-with-cvs-over-insulin-price-manipulation/ https://hawaiimedicaljournal.org/category/public-health/2026/03/ftc-settles-with-cvs-over-insulin-price-manipulation/ Sun, 29 Mar 2026 16:01:37 GMT The FTC reached a proposed settlement with CVS Caremark over allegations its PBM artificially inflated insulin prices and blocked patient access. Robert Kim Public Health https://hawaiimedicaljournal.org/category/medical-technology/2026/03/radiologists-cant-spot-ai-deepfake-x-rays-study-finds/ https://hawaiimedicaljournal.org/category/medical-technology/2026/03/radiologists-cant-spot-ai-deepfake-x-rays-study-finds/ Sun, 29 Mar 2026 04:03:53 GMT A 2026 Radiology study reveals board-certified radiologists cannot reliably detect AI-generated chest X-rays, raising serious patient safety concerns. Priya Patel Medical Technology https://hawaiimedicaljournal.org/category/clinical-research/2026/03/electronic-marking-systems-to-prevent-medical-exam-errors/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/electronic-marking-systems-to-prevent-medical-exam-errors/ Sun, 29 Mar 2026 04:02:23 GMT The AoMRC has issued guidance urging royal colleges to adopt electronic marking systems after a blunder affected nearly 300 physician exam candidates. Michael O'Connor Clinical Research https://hawaiimedicaljournal.org/category/infectious-disease/2026/03/pfizer-lyme-vaccine-shows-70-efficacy-but-misses/ https://hawaiimedicaljournal.org/category/infectious-disease/2026/03/pfizer-lyme-vaccine-shows-70-efficacy-but-misses/ Sat, 28 Mar 2026 04:03:52 GMT Pfizer and Valneva's Lyme disease vaccine reduced infection risk by over 70%, but failed to meet its prespecified statistical threshold in clinical trials. Michael O'Connor Infectious Disease https://hawaiimedicaljournal.org/category/infectious-disease/2026/03/insmeds-arikayce-succeeds-in-phase-3-mac-lung-trial/ https://hawaiimedicaljournal.org/category/infectious-disease/2026/03/insmeds-arikayce-succeeds-in-phase-3-mac-lung-trial/ Sat, 28 Mar 2026 04:02:27 GMT Insmed's Arikayce met primary endpoints in a phase 3 trial for treatment-naive MAC lung infection patients, improving symptoms and culture conversion rates. James Liu Infectious Disease https://hawaiimedicaljournal.org/category/clinical-research/2026/03/fda-approves-kresladi-gene-therapy-for-rare-lad-1-disease/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/fda-approves-kresladi-gene-therapy-for-rare-lad-1-disease/ Sat, 28 Mar 2026 04:00:58 GMT The FDA has approved Rocket Pharma's Kresladi for LAD-1, a rare immunodeficiency affecting roughly 25 US patients annually, marking a gene therapy milestone. Robert Kim Clinical Research https://hawaiimedicaljournal.org/category/medical-technology/2026/03/doctronic-raises-40m-series-b-to-expand-ai-clinical-care/ https://hawaiimedicaljournal.org/category/medical-technology/2026/03/doctronic-raises-40m-series-b-to-expand-ai-clinical-care/ Fri, 27 Mar 2026 04:03:49 GMT Doctronic, an AI-assisted telehealth startup, closed a $40M Series B in March 2026, bringing total funding to $65M in under twelve months. Priya Patel Medical Technology https://hawaiimedicaljournal.org/category/clinical-research/2026/03/how-to-become-a-more-compassionate-clinical-leader/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/how-to-become-a-more-compassionate-clinical-leader/ Fri, 27 Mar 2026 04:02:17 GMT Discover evidence-based principles of compassionate leadership in healthcare, addressing physician burnout and workforce retention in clinical settings. Robert Kim Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/novo-nordisk-faces-investor-pressure-at-2026-annual-meeting/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/novo-nordisk-faces-investor-pressure-at-2026-annual-meeting/ Fri, 27 Mar 2026 04:00:49 GMT Novo Nordisk faces shareholder scrutiny as its stock drops 45% since CEO ouster, while rival Eli Lilly surges to a $1 trillion market cap. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/public-health/2026/03/24-states-sue-epa-over-greenhouse-gas-endangerment-rollback/ https://hawaiimedicaljournal.org/category/public-health/2026/03/24-states-sue-epa-over-greenhouse-gas-endangerment-rollback/ Thu, 26 Mar 2026 04:03:45 GMT A 24-state coalition sues the EPA over its rescission of the 2009 endangerment finding, with major public health and climate regulation implications. Michael O'Connor Public Health https://hawaiimedicaljournal.org/category/public-health/2026/03/court-ruling-reverses-rfk-jrs-vaccine-policy-changes/ https://hawaiimedicaljournal.org/category/public-health/2026/03/court-ruling-reverses-rfk-jrs-vaccine-policy-changes/ Thu, 26 Mar 2026 04:02:19 GMT A federal judge reversed HHS vaccine policy changes by RFK Jr., restoring the childhood vaccine schedule and creating a crossroads for the Trump administration. Keala Nakamura Public Health https://hawaiimedicaljournal.org/category/public-health/2026/03/auto-enrollment-in-medicare-advantage-plans-under-review/ https://hawaiimedicaljournal.org/category/public-health/2026/03/auto-enrollment-in-medicare-advantage-plans-under-review/ Thu, 26 Mar 2026 04:00:59 GMT CMS is evaluating automatic enrollment of Medicare beneficiaries into Medicare Advantage plans or ACOs, a major policy shift under the Trump administration. Hawaii Medical Journal Public Health https://hawaiimedicaljournal.org/category/clinical-research/2026/03/fall-prevention-in-stroke-survivors-tailored-interventions/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/fall-prevention-in-stroke-survivors-tailored-interventions/ Wed, 25 Mar 2026 04:04:21 GMT Stroke survivors face 1.5x higher fall risk. New Australian trial evidence supports home-based, individualized programs to reduce falls in this vulnerable group. Sarah Tanaka Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/trump-drug-pricing-flaw-gilead-deal-what-to-know/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/trump-drug-pricing-flaw-gilead-deal-what-to-know/ Wed, 25 Mar 2026 04:03:03 GMT A structural gap in Trump's most-favored nation drug pricing framework raises doubts, while Gilead Sciences makes a major autoimmune therapeutics acquisition. Robert Kim Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/fast-trial-home-intervention-cuts-falls-after-stroke-by-33/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/fast-trial-home-intervention-cuts-falls-after-stroke-by-33/ Wed, 25 Mar 2026 04:00:54 GMT A randomised trial shows a tailored home-based physiotherapy intervention reduces fall rates by one third in community-dwelling stroke survivors. Priya Patel Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/rethinking-egfr-monitoring-in-chronic-kidney-disease/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/rethinking-egfr-monitoring-in-chronic-kidney-disease/ Tue, 24 Mar 2026 04:04:22 GMT New evidence challenges single eGFR measurements in CKD, suggesting GFR decline trajectory is more clinically actionable than point-in-time precision. Sarah Tanaka Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/apogees-zumilokibart-shows-promise-for-eczema-in-2026/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/apogees-zumilokibart-shows-promise-for-eczema-in-2026/ Tue, 24 Mar 2026 04:02:18 GMT Apogee Therapeutics' zumilokibart showed skin clearance and itch relief for atopic dermatitis with less frequent injections in mid-stage trial results. Robert Kim Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/iran-conflict-pharma-supply-chain-pfizer-lyme-vaccine/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/iran-conflict-pharma-supply-chain-pfizer-lyme-vaccine/ Tue, 24 Mar 2026 04:00:57 GMT Analysts warn Iran conflict could disrupt pharma supply chains via Strait of Hormuz, while Pfizer's Lyme disease vaccine shows promise in Phase 3 trials. Sarah Tanaka Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/vats-vs-open-lobectomy-survival-ipd-meta-analysis/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/vats-vs-open-lobectomy-survival-ipd-meta-analysis/ Mon, 23 Mar 2026 04:03:38 GMT A Lancet IPD meta-analysis finds VATS lobectomy significantly improves overall survival versus open thoracotomy in early-stage NSCLC patients. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/hydration-for-kidney-stones-rct-adherence-intervention/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/hydration-for-kidney-stones-rct-adherence-intervention/ Mon, 23 Mar 2026 04:02:20 GMT A Lancet RCT tested a structured hydration intervention for urinary stone prevention, finding modest urine output gains but no significant reduction in recurrence. James Liu Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/surgical-approach-and-long-term-lung-cancer-outcomes-2026/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/surgical-approach-and-long-term-lung-cancer-outcomes-2026/ Mon, 23 Mar 2026 04:01:00 GMT A Lancet commentary argues surgical technique is a key variable in lung cancer outcomes, urging rigorous trial design to evaluate minimally invasive approaches. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/cms-chief-tempers-trumprx-expectations-in-2026/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/cms-chief-tempers-trumprx-expectations-in-2026/ Sun, 22 Mar 2026 04:03:20 GMT CMS administrator Chris Klomp clarified TrumpRx targets the uninsured, not most Americans, countering President Trump's broader claims about the drug discount platform. Robert Kim Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/creatinine-vs-cystatin-c-gfr-accuracy-in-moderate-ckd/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/creatinine-vs-cystatin-c-gfr-accuracy-in-moderate-ckd/ Sun, 22 Mar 2026 04:02:08 GMT A BMJ cohort study finds combined creatinine and cystatin C equations outperform creatinine-alone GFR estimates in monitoring moderate chronic kidney disease. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/eli-lillys-retatrutide-cuts-blood-sugar-weight-in-trial/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/eli-lillys-retatrutide-cuts-blood-sugar-weight-in-trial/ Sun, 22 Mar 2026 04:00:56 GMT Eli Lilly's triple-G drug retatrutide showed significant HbA1C and weight reductions in type 2 diabetes patients at 40 weeks in a 2026 late-stage trial. Michael O'Connor Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/how-a-texas-couple-got-rich-off-out-of-network-bills/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/how-a-texas-couple-got-rich-off-out-of-network-bills/ Sat, 21 Mar 2026 04:04:20 GMT Scott and Alla LaRoque built wealth through HaloMD, exploiting federal arbitration meant to protect patients from surprise medical bills. Sarah Tanaka Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/jjs-icotyde-first-oral-psoriasis-pill-fda-approved-2026/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/jjs-icotyde-first-oral-psoriasis-pill-fda-approved-2026/ Sat, 21 Mar 2026 04:02:11 GMT The FDA approved icotrokinra (Icotyde) in March 2026, marking the first oral once-daily pill in its class for moderate to severe plaque psoriasis. James Liu Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/golden-bridge-ii-trial-cdss-improves-stroke-outcomes/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/golden-bridge-ii-trial-cdss-improves-stroke-outcomes/ Sat, 21 Mar 2026 04:00:52 GMT A cluster RCT of 21,603 stroke patients across 77 Chinese hospitals shows AI-powered clinical decision support significantly reduces vascular events. Priya Patel Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/arpa-h-develops-fda-authorized-ai-agents-for-clinical-use/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/arpa-h-develops-fda-authorized-ai-agents-for-clinical-use/ Fri, 20 Mar 2026 16:03:44 GMT ARPA-H is advancing FDA-authorized AI clinical tools in 2026, pairing federal research funding with mandatory clinical trial validation and deployment pathways. Robert Kim Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/fda-approves-high-dose-wegovy-72mg-for-obesity-in-2026/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/fda-approves-high-dose-wegovy-72mg-for-obesity-in-2026/ Fri, 20 Mar 2026 16:02:20 GMT The FDA approved high-dose semaglutide 7.2mg (Wegovy) for obesity, showing 18.7% mean weight loss in Phase 3 trials amid new Trump administration drug pricing agreements. Sarah Tanaka Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/medicare-chief-trumprx-is-narrow-in-scope-not-a-full-fix/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/medicare-chief-trumprx-is-narrow-in-scope-not-a-full-fix/ Fri, 20 Mar 2026 16:00:59 GMT Medicare chief Chris Klomp says TrumpRx is a limited cash-pay tool, not a sweeping drug pricing overhaul, tempering Trump's transformative claims. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/cancer-cells-surface-proteins-new-immunotherapy-targets-2026/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/cancer-cells-surface-proteins-new-immunotherapy-targets-2026/ Wed, 18 Mar 2026 04:04:26 GMT UCSF researchers found oncogenic protein Src on cancer cell surfaces, potentially creating new immunotherapy targets for hard-to-treat solid tumors. Priya Patel Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/medpac-2026-76b-medicare-advantage-overpayment-warning/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/medpac-2026-76b-medicare-advantage-overpayment-warning/ Wed, 18 Mar 2026 04:03:07 GMT MedPAC projects $76 billion in excess Medicare Advantage payments in 2026, urging Congress to reform spending as industry pressure mounts. Sarah Tanaka Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/trump-drug-pricing-gsk-asthma-inhaler-controversy-2026/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/trump-drug-pricing-gsk-asthma-inhaler-controversy-2026/ Wed, 18 Mar 2026 04:01:46 GMT The White House pushes most-favored-nation drug pricing legislation while a Senate report scrutinizes GSK's asthma inhaler discontinuation strategy. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/aldeyra-therapeutics-fda-review-red-flags-short-sellers/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/aldeyra-therapeutics-fda-review-red-flags-short-sellers/ Tue, 17 Mar 2026 04:03:33 GMT Aldeyra Therapeutics faces FDA scrutiny amid short-seller pressure as its regulatory decision window approaches. What clinicians need to know in 2026. James Liu Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/phila-trial-pyrotinib-survival-results-in-her2-breast-cancer/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/phila-trial-pyrotinib-survival-results-in-her2-breast-cancer/ Tue, 17 Mar 2026 04:02:05 GMT Long-term PHILA trial data show pyrotinib plus trastuzumab and docetaxel delivers significant survival benefit in HER2-positive metastatic breast cancer. Hawaii Medical Journal Clinical Research https://hawaiimedicaljournal.org/category/clinical-research/2026/03/oral-obesity-pill-phase-2-results-cholesterol-guidelines/ https://hawaiimedicaljournal.org/category/clinical-research/2026/03/oral-obesity-pill-phase-2-results-cholesterol-guidelines/ Tue, 17 Mar 2026 04:00:55 GMT Structure Therapeutics reports 16% weight loss in Phase 2 oral GLP-1 trial, plus GSK's Arexvy expansion and new cholesterol guideline updates. Keala Nakamura Clinical Research https://hawaiimedicaljournal.org/category/medical-technology/2026/03/digital-marketplaces-reshaping-lab-procurement-2026/ https://hawaiimedicaljournal.org/category/medical-technology/2026/03/digital-marketplaces-reshaping-lab-procurement-2026/ Mon, 16 Mar 2026 09:00:00 GMT As biotech and pharmaceutical teams grapple with fragmented vendor networks and chronic supply delays, a new class of digital procurement marketplaces is emerging to streamline how labs order everything from reagents to research equipment. Priya Patel Medical Technology